BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24951113)

  • 1. Is the volume of low-grade glioma measurable and is it clinically relevant?
    Chamberlain MC
    Neuro Oncol; 2014 Aug; 16(8):1027-8. PubMed ID: 24951113
    [No Abstract]   [Full Text] [Related]  

  • 2. Link between rosacea and glioma in nationwide cohort.
    Bagcchi S
    Lancet Oncol; 2016 Mar; 17(3):e94. PubMed ID: 26853822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Editorial comment on the occurrence and molecular pathology of low grade and high grade gliomas].
    Kopniczky Z
    Ideggyogy Sz; 2013 Sep; 66(9-10):322. PubMed ID: 24358687
    [No Abstract]   [Full Text] [Related]  

  • 4. Does risk of brain cancer increase with intracranial volume? A population-based case control study.
    Fyllingen EH; Hansen TI; Jakola AS; Håberg AK; Salvesen Ø; Solheim O
    Neuro Oncol; 2018 Aug; 20(9):1225-1230. PubMed ID: 29554311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas.
    Pallud J; Mandonnet E; Duffau H; Kujas M; Guillevin R; Galanaud D; Taillandier L; Capelle L
    Ann Neurol; 2006 Sep; 60(3):380-3. PubMed ID: 16983683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laterality of brain tumors.
    Inskip PD; Tarone RE; Hatch EE; Wilcosky TC; Selker RG; Fine HA; Black PM; Loeffler JS; Shapiro WR; Linet MS
    Neuroepidemiology; 2003; 22(2):130-8. PubMed ID: 12629279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Grade Glioma: Epidemiology, Pathophysiology, Clinical Features, and Treatment.
    McKhann GM; Duffau H
    Neurosurg Clin N Am; 2019 Jan; 30(1):xiii-xiv. PubMed ID: 30470410
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin.
    Smith TR; Hulou MM; Abecassis J; Das S; Chandler JP
    J Clin Neurosci; 2015 Sep; 22(9):1397-402. PubMed ID: 26055954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-treatment magnetic resonance imaging in pediatric intracranial low-grade gliomas treated with proton beam therapy.
    Kumar RS; Rotondo RL; Bradley JA; Vern-Gross T; Huh S; Indelicato DJ
    Acta Oncol; 2017 Sep; 56(9):1243-1247. PubMed ID: 28339304
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
    Chaichana KL; McGirt MJ; Niranjan A; Olivi A; Burger PC; Quinones-Hinojosa A
    Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic gliomas: an emerging entity.
    Wick W
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S357-8. PubMed ID: 21944014
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.
    Corell A; Ferreyra Vega S; Hoefling N; Carstam L; Smits A; Olsson Bontell T; Björkman-Burtscher IM; Carén H; Jakola AS
    BMC Cancer; 2020 May; 20(1):450. PubMed ID: 32434559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Occurrence and molecular pathology of low grade gliomas].
    Murnyák B; Csonka T; Klekner A; Hortobágyi T
    Ideggyogy Sz; 2013 Sep; 66(9-10):305-11. PubMed ID: 24358685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell phones and glioma risk: a review of the evidence.
    Corle C; Makale M; Kesari S
    J Neurooncol; 2012 Jan; 106(1):1-13. PubMed ID: 21853424
    [No Abstract]   [Full Text] [Related]  

  • 15. Morbidity in patients with intracranial gliomas.
    Gibberd FB; Scott GM
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):460. PubMed ID: 6101188
    [No Abstract]   [Full Text] [Related]  

  • 16. A meta-analysis of arterial spin labelling perfusion values for the prediction of glioma grade.
    Kong L; Chen H; Yang Y; Chen L
    Clin Radiol; 2017 Mar; 72(3):255-261. PubMed ID: 27932251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Larotrectinib imaging response in low-grade glioma.
    Walter AW; Kandula VVR; Shah N
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28002. PubMed ID: 31544356
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis.
    Eichberg DG; Di L; Morell AA; Shah AH; Semonche AM; Chin CN; Bhatia RG; Jamshidi AM; Luther EM; Komotar RJ; Ivan ME
    J Neurooncol; 2020 May; 147(3):671-679. PubMed ID: 32221785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular pathology of intrinsic brain tumours.
    Merzak A; Pilkington GJ
    Cancer Metastasis Rev; 1997 Jun; 16(1-2):155-77. PubMed ID: 9156285
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment to the article: Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
    Stummer W
    Cent Eur Neurosurg; 2011 May; 72(2):70. PubMed ID: 21698825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.